SG11202008901WA - Ophthalmic compositions, and ocular uses thereof, of indigo carmine - Google Patents
Ophthalmic compositions, and ocular uses thereof, of indigo carmineInfo
- Publication number
- SG11202008901WA SG11202008901WA SG11202008901WA SG11202008901WA SG11202008901WA SG 11202008901W A SG11202008901W A SG 11202008901WA SG 11202008901W A SG11202008901W A SG 11202008901WA SG 11202008901W A SG11202008901W A SG 11202008901WA SG 11202008901W A SG11202008901W A SG 11202008901WA
- Authority
- SG
- Singapore
- Prior art keywords
- ophthalmic compositions
- indigo carmine
- ocular uses
- ocular
- carmine
- Prior art date
Links
- KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 title 1
- 229960003988 indigo carmine Drugs 0.000 title 1
- 235000012738 indigotine Nutrition 0.000 title 1
- 239000004179 indigotine Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00736—Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0023—Di-or triarylmethane dye
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
- A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
- A61K49/0043—Fluorescein, used in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0071—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form solution, solute
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biodiversity & Conservation Biology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Medicinal Preparation (AREA)
- Prostheses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862644176P | 2018-03-16 | 2018-03-16 | |
PCT/AU2019/050232 WO2019173877A1 (en) | 2018-03-16 | 2019-03-15 | Ophthalmic compositions, and ocular uses thereof, of indigo carmine |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202008901WA true SG11202008901WA (en) | 2020-10-29 |
Family
ID=67907429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202008901WA SG11202008901WA (en) | 2018-03-16 | 2019-03-15 | Ophthalmic compositions, and ocular uses thereof, of indigo carmine |
Country Status (7)
Country | Link |
---|---|
US (2) | US11679167B2 (en) |
EP (1) | EP3765095A4 (en) |
CN (2) | CN112105392B (en) |
AU (1) | AU2019233843A1 (en) |
CA (1) | CA3093707A1 (en) |
SG (1) | SG11202008901WA (en) |
WO (1) | WO2019173877A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3765095A4 (en) | 2018-03-16 | 2021-11-24 | Minas Theodore Coroneo | Ophthalmic compositions, and ocular uses thereof, of indigo carmine |
CN114173724A (en) * | 2019-03-15 | 2022-03-11 | 米纳斯·希欧多尔·科罗内奥 | Ophthalmic compositions of indigo carmine and ophthalmic uses thereof |
EP3993743A4 (en) * | 2019-07-01 | 2023-07-26 | Michael S. Berlin | Image guidance methods and apparatus for glaucoma surgery |
CN113208810B (en) * | 2021-05-18 | 2022-04-12 | 南方医科大学深圳医院 | Ultrasonic drug delivery device for SMILE (small inert laser ablation) lens dyeing low-temperature separation liquid |
CN115956574A (en) * | 2022-12-30 | 2023-04-14 | 烟台爱博诺德医用材料有限公司 | Care composition for optical devices |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1028696A (en) | 1996-07-16 | 1998-02-03 | Akurosu:Kk | Trapper for splash from oral cavity, for dental treatment |
RU2131234C1 (en) * | 1997-07-11 | 1999-06-10 | Филиал ЗАО МНТК "Микрохирургия глаза", Хабаровский региональный центр | Method for setting intraoperation diagnosis of retinal raptures in performing operations related to regmatogenic retinal detachment |
US8679089B2 (en) | 2001-05-21 | 2014-03-25 | Michael S. Berlin | Glaucoma surgery methods and systems |
US7014991B2 (en) * | 2001-11-16 | 2006-03-21 | Infinite Vision, Llc | Use of injectable dyes for staining an anterior lens capsule and vitreo-retinal interface |
TW519899U (en) | 2002-06-13 | 2003-02-01 | Chin-Liang Lin | Air screen device for eye examination instrument |
WO2004082541A1 (en) * | 2003-03-17 | 2004-09-30 | Infinite Vision, Llc | Device for staining an interior eye structure |
US20050283108A1 (en) | 2004-06-10 | 2005-12-22 | Savage James A | Apparatus and method for non-pharmacological treatment of glaucoma and lowering intraocular pressure |
US20060081726A1 (en) | 2004-10-14 | 2006-04-20 | Gerondale Scott J | Controlled drop dispensing tips for bottles |
PT2526910E (en) | 2006-01-17 | 2015-11-18 | Transcend Medical Inc | Glaucoma treatment device |
US7823586B2 (en) | 2007-07-25 | 2010-11-02 | Mark Glazman | Personal respiratory protection system |
US10029797B2 (en) | 2008-09-30 | 2018-07-24 | The Boeing Company | Personal ventilation in an aircraft environment |
US20100234794A1 (en) | 2009-03-12 | 2010-09-16 | Kevin Shaun Weadock | System and method for reducing surgical site infection |
RU2407567C1 (en) | 2009-10-23 | 2010-12-27 | Олег Игоревич Осипов | Method of respiratory and eye protection against aerosols and protection device for implementation thereof |
JP2013508096A (en) | 2009-10-23 | 2013-03-07 | イバンティス インコーポレイテッド | Intraocular transplantation system and intraocular transplantation method |
AU2015202819B2 (en) * | 2010-04-01 | 2016-10-27 | D.O.R.C. Dutch Ophthalmic Research Center (International) BV | Staining composition |
US20110290752A1 (en) | 2010-05-27 | 2011-12-01 | Yeager Don F | Inverted bottle assembly |
BR112013024951A2 (en) * | 2011-03-29 | 2016-12-20 | Kemin Ind Inc | method of treating biological tissues, membranes or other structures, and composition for staining biological tissues, membranes or other structures |
US20140102442A1 (en) | 2012-10-15 | 2014-04-17 | Roger D. Wilson | Facial accessory system |
US20180325731A1 (en) | 2017-05-15 | 2018-11-15 | Rainbow Medical Ltd. | Eye implant |
EP3765095A4 (en) | 2018-03-16 | 2021-11-24 | Minas Theodore Coroneo | Ophthalmic compositions, and ocular uses thereof, of indigo carmine |
US10993909B1 (en) | 2020-03-20 | 2021-05-04 | Virothera Pharmaceuticals LLC | Method and composition for treating upper respiratory tract inflammatory and infectious diseases |
CN111419787A (en) | 2020-04-16 | 2020-07-17 | 广州康健医学科技有限公司 | Chloroquine spray and preparation method thereof |
CN112978328A (en) | 2021-03-05 | 2021-06-18 | 福安市中虹机电技术开发有限公司 | Semi-automatic feeder |
-
2019
- 2019-03-15 EP EP19767725.5A patent/EP3765095A4/en active Pending
- 2019-03-15 WO PCT/AU2019/050232 patent/WO2019173877A1/en active Application Filing
- 2019-03-15 US US16/980,547 patent/US11679167B2/en active Active
- 2019-03-15 CN CN201980031701.2A patent/CN112105392B/en active Active
- 2019-03-15 AU AU2019233843A patent/AU2019233843A1/en active Pending
- 2019-03-15 SG SG11202008901WA patent/SG11202008901WA/en unknown
- 2019-03-15 CN CN202310719249.7A patent/CN116747324A/en active Pending
- 2019-03-15 CA CA3093707A patent/CA3093707A1/en active Pending
-
2024
- 2024-01-22 US US18/419,184 patent/US20240156992A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2019173877A1 (en) | 2019-09-19 |
US20240156992A1 (en) | 2024-05-16 |
US20210000979A1 (en) | 2021-01-07 |
CA3093707A1 (en) | 2019-03-15 |
EP3765095A1 (en) | 2021-01-20 |
EP3765095A4 (en) | 2021-11-24 |
AU2019233843A1 (en) | 2020-10-08 |
CN112105392A (en) | 2020-12-18 |
CN116747324A (en) | 2023-09-15 |
CN112105392B (en) | 2023-06-20 |
US11679167B2 (en) | 2023-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202008901WA (en) | Ophthalmic compositions, and ocular uses thereof, of indigo carmine | |
EP3525885A4 (en) | Artificial tear, contact lens and drug vehicle compositions and methods of use thereof | |
EP3624773A4 (en) | Ophthalmic compositions and methods of use | |
EP3413851A4 (en) | Ocular injection kit, packaging, and methods of use | |
MX2022000754A (en) | Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization. | |
EP3310356A4 (en) | Compositions for the improvement of distance vision and the treatment of refractive errors of the eye | |
EP3829569A4 (en) | Spinosyn formulations for treatment of demodex-induced ocular and facial conditions | |
EP3651747A4 (en) | Compositions and methods for the treatment of eye disorders | |
EP3672523A4 (en) | Single piece intra-ocular lenses and methods of manufacture thereof | |
EP3265096A4 (en) | Ophthalmic compositions and methods of use therefor | |
IL273531A (en) | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases | |
EP3515444A4 (en) | Composition for treating ocular diseases and methods of usage and making | |
EP3481411A4 (en) | Treatment for glaucoma and other eye diseases | |
IL282504A (en) | Ocular formulations for drug-delivery and protection of the anterior segment of the eye | |
EP3481808A4 (en) | Trpa1 antagonists for treatment of dry eye, ocular pain and inflammation | |
EP3685828A4 (en) | Ophthalmic pharmaceutical composition, ophthalmic kit, and pharmaceutical application thereof | |
EP3703613A4 (en) | Intraocular lenses and peripheral portion stabilization | |
EP3654964A4 (en) | Composition and methods for the treatment of myopia | |
EP3618850A4 (en) | Compositions and methods for treating ocular pathologies | |
EP3644966A4 (en) | Treatment and diagnosis of ocular surface disorders | |
EP3452015A4 (en) | Compositions and methods for treatment of inflammation or infection of the eye | |
EP3813794A4 (en) | Ophthalmic compositions and methods for the treatment of eye disorders | |
EP3853317A4 (en) | Artificial tear, contact lens and drug vehicle compositions and methods of use thereof | |
PL3720428T3 (en) | Ophthalmic topical composition comprisng dobesilic acid for treating diseases of the posterior segment of the eye | |
IL282898A (en) | Ophthalmic compositions and methods for the treatment of skin diseases and eye diseases |